SHAMEKA BOLTON: Open Payments
NPI 1568700029 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,552 in 14 payments from 11 companies in 2025. Trend: 2023 $341 · 2024 $1,266 · 2025 $1,552
Food & beverage: $1,552
| Company | Payments | Amount |
|---|---|---|
| Alexion Pharmaceuticals, Inc. | 2 | $258 |
| AstraZeneca Pharmaceuticals LP | 2 | $224 |
| Stryker Corporation | 1 | $171 |
| Neurocrine BioSciences, Inc. | 2 | $160 |
| Paratek Pharmaceuticals, Inc. | 1 | $125 |
| Otsuka America Pharmaceutical, Inc. | 1 | $122 |
| ABBVIE INC. | 1 | $118 |
| ACADIA Pharmaceuticals Inc | 1 | $118 |
| Lilly USA, LLC | 1 | $112 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $99 |
Products named: ULTOMIRIS, FLOWTRIEVER CATHETER, S, NUZYRA, REXULTI, BREZTRI, MAVYRET, NUPLAZID, AIRSUPRA.
Industry payments across TX — which companies pay providers there.
